Response to heart failure treatment in patients with anthracyclines and trastuzumab induced left ventricular dysfunction

Authors: S Del Castillo, L Fileni, C Llamedo, S Capdeville, C Scarponi, C Belziti, M Falconi, D Perez De Arenaza, E Rossi, R Pizarro

Published: 2022-10-15

DOI: 10.1093/eurheartj/ehac544.799

Source: Full article